Early research (Phase 1)Study completedNCT06890299
What this trial is testing
Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed Conditions
Who this might be right for
Type 2 Diabetes
Boryung Pharmaceutical Co., Ltd 40